RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
G
ABCA1
ATP binding cassette subfamily A member 1
IEP
mRNA:increased expression:liver (human)
RGD
PMID:28660384
RGD:21203516
NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155
G
ABCB4
ATP binding cassette subfamily B member 4
treatment disease_progression
EXP ISO IAGP
CTD Direct Evidence: marker/mechanism DNA:SNPs, haplotype, diplotype: : rs31658, rs31672,rs1149222(human)
CTD RGD
PMID:20040336 PMID:30682444 PMID:21209952 PMID:18671305
RGD:153297773 , RGD:14694982
NCBI chr 7:87,365,896...87,476,027
Ensembl chr 7:87,401,696...87,480,435
G
ABCC2
ATP binding cassette subfamily C member 2
EXP ISO
CTD Direct Evidence: marker/mechanism protein:decreased expression:liver
CTD RGD
PMID:15542527 PMID:15770136
RGD:14700810
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
G
ABCG2
ATP binding cassette subfamily G member 2 (JR blood group)
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15542527
NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628
G
ACE
angiotensin I converting enzyme
ISO
mRNA:increased expression:liver
RGD
PMID:19389807
RGD:2325226
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
G
ACE2
angiotensin converting enzyme 2
ISO
mRNA, protein:increased expression:liver
RGD
PMID:17532087
RGD:9685452
NCBI chr X:15,518,197...15,607,211
Ensembl chr X:15,494,566...15,607,236
G
AGT
angiotensinogen
ISO
protein:increased expression:plasma
RGD
PMID:17532087
RGD:9685452
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
G
ALB
albumin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
G
AQP4
aquaporin 4
ISO
RGD
PMID:20451280
RGD:5148030
NCBI chr18:26,852,038...26,865,803
Ensembl chr18:26,852,043...26,865,771
G
CCL5
C-C motif chemokine ligand 5
EXP IEP
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver:
CTD RGD
PMID:12126966 PMID:15770052
RGD:14995336
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
CCN2
cellular communication network factor 2
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:19371232
RGD:2314517
NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372
G
CD3D
CD3 delta subunit of T-cell receptor complex
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr11:118,338,954...118,342,705
Ensembl chr11:118,339,075...118,342,705
G
CD80
CD80 molecule
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr 3:119,524,293...119,559,614
Ensembl chr 3:119,524,293...119,559,614
G
CDH5
cadherin 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr16:66,366,691...66,404,784
Ensembl chr16:66,366,690...66,404,784
G
CDKN1A
cyclin dependent kinase inhibitor 1A
IEP
protein:increased expression:epithelial cell:
RGD
PMID:18456456
RGD:8662434
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
G
CENPB
centromere protein B
IDA
RGD
PMID:8911074
RGD:27226708
NCBI chr20:3,783,851...3,786,740
Ensembl chr20:3,783,851...3,786,740
G
CLEC16A
C-type lectin domain containing 16A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr16:10,944,564...11,182,186
Ensembl chr16:10,944,539...11,182,186
G
COL1A1
collagen type I alpha 1 chain
treatment
ISO
RGD
PMID:20056896
RGD:8552731
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
G
CPEB1
cytoplasmic polyadenylation element binding protein 1
ISO
protein:increased expression:liver
RGD
PMID:26627607
RGD:11528851
NCBI chr15:82,543,201...82,648,795
Ensembl chr15:82,543,201...82,648,861
G
CPEB4
cytoplasmic polyadenylation element binding protein 4
IEP
protein:increased expression:liver
RGD
PMID:26627607
RGD:11528851
NCBI chr 5:173,888,349...173,961,980
Ensembl chr 5:173,888,349...173,961,980
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
susceptibility disease_progression no_association
IAGP
autoimmune biliary cirrhosis; DNA:SNP:CDS:49A>G, significant association with G allele (p<0.0002) DNA:SNP:CDS:60G>A(rs3087243)(human) DNA:SNPs: :rs231775, rs3087243, rs231725 (human) DNA:SNP:CDS:49A>G(human)
RGD
PMID:10782900 PMID:16584111 PMID:21594562 PMID:17482523
RGD:2301998 , RGD:14398744 , RGD:14398743 , RGD:14398725
NCBI chr 2:203,867,771...203,873,965
Ensembl chr 2:203,853,888...203,873,965
G
CXCL10
C-X-C motif chemokine ligand 10
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
G
CXCL8
C-X-C motif chemokine ligand 8
IEP
mRNA:increased expression:liver (human)
RGD
PMID:21731723
RGD:26884357
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CXCL9
C-X-C motif chemokine ligand 9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr 4:76,001,275...76,007,509
Ensembl chr 4:76,001,275...76,007,509
G
CXCR5
C-X-C motif chemokine receptor 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr11:118,883,892...118,897,787
Ensembl chr11:118,883,892...118,897,787
G
CYGB
cytoglobin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr17:76,527,356...76,551,193
Ensembl chr17:76,527,356...76,551,175
G
DAG1
dystroglycan 1
ISO
mRNA:increased expression:liver
RGD
PMID:12177244
RGD:2314895
NCBI chr 3:49,468,948...49,535,615
Ensembl chr 3:49,468,713...49,535,618
G
DENND1B
DENN domain containing 1B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr 1:197,504,748...197,782,150
Ensembl chr 1:197,504,748...197,775,696
G
DNASE1
deoxyribonuclease 1
IEP
protein:decreased activity:serum (human)
RGD
PMID:28263100
RGD:38500241
NCBI chr16:3,611,760...3,665,461
Ensembl chr16:3,611,728...3,680,143
G
ENTPD2
ectonucleoside triphosphate diphosphohydrolase 2
IEP EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15651265 PMID:15651265
RGD:9685530
NCBI chr 9:137,048,107...137,054,061
Ensembl chr 9:137,048,107...137,054,061
G
FAS
Fas cell surface death receptor
IEP
protein:increased expression:lymphocyte:
RGD
PMID:26429926
RGD:14700711
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
G
FOXP3
forkhead box P3
IEP
mRNA:increased expression:liver
RGD
PMID:17158635
RGD:38501106
NCBI chr X:49,250,438...49,264,710
Ensembl chr X:49,250,438...49,264,800
G
GCH1
GTP cyclohydrolase 1
treatment
ISO
RGD
PMID:20132096
RGD:329970291
NCBI chr14:54,842,017...54,902,826
Ensembl chr14:54,842,008...54,902,826
G
HAMP
hepcidin antimicrobial peptide
treatment
IEP ISO
mRNA:decreased expression:liver
RGD
PMID:19652645 PMID:23704825
RGD:11041639 , RGD:11041732
NCBI chr19:35,282,528...35,285,143
Ensembl chr19:35,280,716...35,285,143
G
HHIP
hedgehog interacting protein
ISO
mRNA:decreased expression:
RGD
PMID:18375471
RGD:11552599
NCBI chr 4:144,646,156...144,745,271
Ensembl chr 4:144,646,156...144,745,271
G
HIF1A
hypoxia inducible factor 1 subunit alpha
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22271822
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
G
HLA-DQA1
major histocompatibility complex, class II, DQ alpha 1
susceptibility
IAGP
DNA:polymorphism: :
RGD
PMID:15713222
RGD:14401562
NCBI chr 6:32,637,406...32,655,272
Ensembl chr 6:32,628,179...32,647,062
G
HMOX1
heme oxygenase 1
ISO
mRNA, protein:increased expression:liver, lung
RGD
PMID:12114196
RGD:625603
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
ICAM1
intercellular adhesion molecule 1
treatment
ISO
associated with Graft vs Host Disease;
RGD
PMID:10051478
RGD:11520783
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
ICAM3
intercellular adhesion molecule 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr19:10,333,776...10,339,624
Ensembl chr19:10,333,776...10,339,661
G
IFNG
interferon gamma
IEP
mRNA:increased expression:liver
RGD
PMID:17158635
RGD:38501106
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IGFBP1
insulin like growth factor binding protein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr 7:45,888,488...45,893,660
Ensembl chr 7:45,888,360...45,893,660
G
IL10
interleukin 10
IEP
mRNA:increased expression:liver
RGD
PMID:17158635
RGD:38501106
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL12A
interleukin 12A
susceptibility treatment
EXP IAGP
CTD Direct Evidence: marker/mechanism DNA:SNPs, haplotype: :rs6441286, rs574808(human) DNA:SNP: :rs62270414(human) DNA:SNPs:enhancer:rs4679868, rs6441286, rs666251(human)
CTD RGD
PMID:20639880 PMID:19458352 PMID:23433321 PMID:27175695
RGD:25440500 , RGD:25440498 , RGD:25440489
NCBI chr 3:159,988,835...159,996,019
Ensembl chr 3:159,988,835...159,996,019
G
IL12B
interleukin 12B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20639880
NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
G
IL12RB1
interleukin 12 receptor subunit beta 1
susceptibility
IEP
RNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:23910013
RGD:14700865
NCBI chr19:18,058,995...18,098,816
Ensembl chr19:18,058,995...18,098,944
G
IL4
interleukin 4
treatment
ISO
RGD
PMID:20442198
RGD:7829828
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
IL7R
interleukin 7 receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr 5:35,856,891...35,879,603
Ensembl chr 5:35,852,695...35,879,603
G
JAK2
Janus kinase 2
treatment
ISO
RGD
PMID:24619965
RGD:10403061
NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948
G
KEAP1
kelch like ECH associated protein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558
G
KRT18
keratin 18
severity
IEP
protein:increased expression:serum (human)
RGD
PMID:26110613
RGD:18337483
NCBI chr12:52,948,855...52,952,906
Ensembl chr12:52,948,871...52,952,906
G
KRT7
keratin 7
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21681009
NCBI chr12:52,233,243...52,255,853
Ensembl chr12:52,232,520...52,252,186
G
LBR
lamin B receptor
IDA
RGD
PMID:8550049
RGD:9588625
NCBI chr 1:225,401,502...225,428,821
Ensembl chr 1:225,401,502...225,428,925
G
LEP
leptin
IEP
protein:decreased expression:serum:
RGD
PMID:16093869
RGD:10411894
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
G
LEPR
leptin receptor
IEP
protein:increased expression:blood serum
RGD
PMID:16093869
RGD:10411894
NCBI chr 1:65,420,652...65,641,559
Ensembl chr 1:65,420,652...65,641,559
G
LOX
lysyl oxidase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16023247
NCBI chr 5:122,063,195...122,078,259
Ensembl chr 5:122,063,195...122,078,413
G
LOXL2
lysyl oxidase like 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16023247
NCBI chr 8:23,296,897...23,404,120
Ensembl chr 8:23,296,897...23,425,328
G
MAP3K14
mitogen-activated protein kinase kinase kinase 14
ISS
OMIM:109720 | OMIM:613007 | OMIM:613008 | OMIM:614220 | OMIM:614221
MouseDO
NCBI chr17:45,263,119...45,317,020
Ensembl chr17:45,263,119...45,317,029
G
MAPK14
mitogen-activated protein kinase 14
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,782...36,111,236
G
MAS1
MAS1 proto-oncogene, G protein-coupled receptor
ISO
RGD
PMID:17532087
RGD:9685452
NCBI chr 6:159,888,787...159,917,447
Ensembl chr 6:159,890,988...159,917,447
G
MET
MET proto-oncogene, receptor tyrosine kinase
severity
ISO
RGD
PMID:19208365
RGD:14694826
NCBI chr 7:116,672,196...116,798,377
Ensembl chr 7:116,672,196...116,798,377
G
MIR21
microRNA 21
severity
IEP
RGD
PMID:28886078
RGD:21408577
NCBI chr17:59,841,266...59,841,337
Ensembl chr17:59,841,266...59,841,337
G
MIR223
microRNA 223
severity
IEP
RGD
PMID:28886078
RGD:21408577
NCBI chr X:66,018,870...66,018,979
Ensembl chr X:66,018,870...66,018,979
G
MMEL1
membrane metalloendopeptidase like 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20639879
NCBI chr 1:2,590,639...2,633,016
Ensembl chr 1:2,590,639...2,633,016
G
MMP13
matrix metallopeptidase 13
treatment
ISO
RGD
PMID:20056896
RGD:8552731
NCBI chr11:102,942,995...102,955,732
Ensembl chr11:102,942,995...102,955,732
G
MMP2
matrix metallopeptidase 2
treatment
ISO
RGD
PMID:20056896
RGD:8552731
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
G
MMP3
matrix metallopeptidase 3
treatment
ISO
RGD
PMID:20056896
RGD:8552731
NCBI chr11:102,835,801...102,843,609
Ensembl chr11:102,835,801...102,843,609
G
MMP9
matrix metallopeptidase 9
treatment
ISO
RGD
PMID:20056896
RGD:8552731
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MUC2
mucin 2, oligomeric mucus/gel-forming
IEP
RGD
PMID:18507686
RGD:2324885
NCBI chr11:1,074,874...1,110,508
Ensembl chr11:1,074,875...1,110,511
G
NFE2L2
NFE2 like bZIP transcription factor 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
G
NFKB1
nuclear factor kappa B subunit 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
G
NOS2
nitric oxide synthase 2
ISO EXP
protein:increased expression, increased activity:brain (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:30026087 PMID:21903766
RGD:5509055
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NOS3
nitric oxide synthase 3
treatment
EXP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:30026087 PMID:20132096
RGD:329970291
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
G
NR1H4
nuclear receptor subfamily 1 group H member 4
susceptibility
IEP
mRNA,protein:decreased expression:liver (human)
RGD
PMID:29968724
RGD:14928336
NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414
G
NR3C1
nuclear receptor subfamily 3 group C member 1
IEP
mRNA:altered expression:leukocyte, mononuclear
RGD
PMID:15635817
RGD:4892607
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
G
NSA2
NSA2 ribosome biogenesis factor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr 5:74,767,249...74,780,113
Ensembl chr 5:74,766,991...74,780,113
G
NUP62
nucleoporin 62
severity
IDA
RGD
PMID:12753810
RGD:9831196
NCBI chr19:49,906,825...49,929,504
Ensembl chr19:49,906,825...49,929,764
G
PDE5A
phosphodiesterase 5A
ISO
RGD
PMID:17610866
RGD:2314466
NCBI chr 4:119,494,403...119,628,804
Ensembl chr 4:119,494,397...119,628,804
G
PPARGC1A
PPARG coactivator 1 alpha
ISO
mRNA, protein:decreased expression:liver
RGD
PMID:
RGD:6484526
NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089
G
RELA
RELA proto-oncogene, NF-kB subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
G
REN
renin
ISO
protein:increased activity:plasma (rat)
RGD
PMID:22266601
RGD:6892690
NCBI chr 1:204,154,819...204,166,337
Ensembl chr 1:204,154,819...204,190,324
G
RPS6KB1
ribosomal protein S6 kinase B1
ISO
protein:increased expression, increased phosphorylation:liver
RGD
PMID:15769867
RGD:1642977
NCBI chr17:59,893,121...59,950,574
Ensembl chr17:59,893,046...59,950,574
G
SLC4A2
solute carrier family 4 member 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18188457
NCBI chr 7:151,058,200...151,076,527
Ensembl chr 7:151,057,210...151,076,526
G
SLC51A
solute carrier family 51 member A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16423920
NCBI chr 3:196,216,534...196,233,427
Ensembl chr 3:196,211,487...196,243,178
G
SLC51B
SLC51 subunit beta
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16423920
NCBI chr15:65,045,387...65,053,397
Ensembl chr15:65,045,387...65,053,397
G
SLCO1C1
solute carrier organic anion transporter family member 1C1
ISO
protein:decreased expression:liver
RGD
PMID:15770136
RGD:14700810
NCBI chr12:20,695,332...20,753,386
Ensembl chr12:20,695,332...20,753,386
G
SOD2
superoxide dismutase 2
IEP
protein:increased expression:serum
RGD
PMID:1682406
RGD:2317411
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
G
SPIB
Spi-B transcription factor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20639880
NCBI chr19:50,418,938...50,431,314
Ensembl chr19:50,418,938...50,431,314
G
SPINT1
serine peptidase inhibitor, Kunitz type 1
ISO
mRNA:increased expression:liver:
RGD
PMID:21898507
RGD:10043111
NCBI chr15:40,844,048...40,858,207
Ensembl chr15:40,844,018...40,858,207
G
SPINT2
serine peptidase inhibitor, Kunitz type 2
ISO
mRNA:increased expression:liver:
RGD
PMID:21898507
RGD:10043111
NCBI chr19:38,264,573...38,292,615
Ensembl chr19:38,244,035...38,292,615
G
STAT4
signal transducer and activator of transcription 4
susceptibility no_association
EXP IAGP
CTD Direct Evidence: marker/mechanism associated with Crohn���s disease; DNA:SNP:intron: (rs7574865) (human) DNA:SNP: intron: (rs7574865) (human) DNA:SNPs:3'utr: (rs7574865, rs8179673, rs10181656) (human) DNA:SNPs, haplotypes:multiple
CTD RGD
PMID:21399635 PMID:26084578 PMID:28395724 PMID:24648611 PMID:24648611
RGD:25671421 , RGD:25671416 , RGD:25671415 , RGD:25671415
NCBI chr 2:191,029,576...191,151,596
Ensembl chr 2:191,029,576...191,151,596
G
TGFB1
transforming growth factor beta 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
TJP2
tight junction protein 2
IAGP
ClinVar Annotator: match by term: Primary biliary cholangitis
ClinVar
PMID:25741868 PMID:28492532 PMID:32439973
NCBI chr 9:69,121,264...69,255,208
Ensembl chr 9:69,121,264...69,274,615
G
TLR9
toll like receptor 9
IEP
protein:increased expression:liver, peripheral blood mononuclear cell (human)
RGD
PMID:23026026
RGD:18337477
NCBI chr 3:52,221,080...52,225,645
Ensembl chr 3:52,221,080...52,225,645
G
TNF
tumor necrosis factor
IEP
protein:increased expression:serum (human) mRNA:increased expression:liver
RGD
PMID:9047083 PMID:17158635
RGD:14995307 , RGD:38501106
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFRSF1A
TNF receptor superfamily member 1A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
G
TYK2
tyrosine kinase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22961000
NCBI chr19:10,350,533...10,380,572
Ensembl chr19:10,350,533...10,380,608
G
UBD
ubiquitin D
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr 6:29,555,515...29,559,732
Ensembl chr 6:29,555,515...29,559,732
G
UTP4
UTP4 small subunit processome component
IAGP
North American Indian childhood cirrhosis, OMIM:604901, R565W
RGD
PMID:12417987
RGD:1600653
NCBI chr16:69,132,649...69,169,021
Ensembl chr16:69,131,291...69,231,130
G
VDR
vitamin D receptor
susceptibility
IEA IAGP
DNA:polymorphism: : DNA:SNP: :
GAD RGD
PMID:15118671 PMID:15683428 PMID:19376604
RGD:1331525 , RGD:14402024 , RGD:14401750
NCBI chr12:47,841,537...47,904,994
Ensembl chr12:47,841,537...47,943,048
G
VEGFA
vascular endothelial growth factor A
ISO IEP
protein:increased expression:liver protein:increased expression:plasma:
RGD
PMID:26627607 PMID:26615570
RGD:11528851 , RGD:11538286
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
ZC3H12A
zinc finger CCCH-type containing 12A
ISS
OMIM:109720 | OMIM:613007 | OMIM:613008 | OMIM:614220 | OMIM:614221
MouseDO
NCBI chr 1:37,474,580...37,484,377
Ensembl chr 1:37,474,580...37,484,377
G
UTP4
UTP4 small subunit processome component
IAGP
ClinVar Annotator: match by term: Hereditary North American Indian childhood cirrhosis
ClinVar
PMID:9536098 PMID:12417987 PMID:16225863 PMID:17576681 PMID:19732766 PMID:20385600 PMID:22916032 PMID:24123366 PMID:25741868 PMID:27535533 PMID:28492532 More...
NCBI chr16:69,132,649...69,169,021
Ensembl chr16:69,131,291...69,231,130
G
IL12RB2
interleukin 12 receptor subunit beta 2
IAGP
ClinVar Annotator: match by term: IL12RB2-related condition
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 1:67,307,364...67,398,724
Ensembl chr 1:67,307,364...67,398,724
G
LBR
lamin B receptor
IAGP EXP
ClinVar Annotator: match by term: Reynolds syndrome CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: PRIMARY BILIARY CIRRHOSIS, SCLERODERMA, RAYNAUD DISEASE, AND TELANGIECTASIA
OMIM ClinVar CTD
PMID:18382993 PMID:20522425 PMID:24033266 PMID:25348816 PMID:25741868 PMID:26467025 PMID:28492532 PMID:32827848 More...
NCBI chr 1:225,401,502...225,428,821
Ensembl chr 1:225,401,502...225,428,925
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all